EyePoint Pharmaceuticals Case Study

We make what matters understood by helping emerging biotech companies explain their value.

Strategic

Define your position and plan your communications

Strategic

Define your position and plan your communications

Scientific

Explain your science and evidence to the right audience

Scientific

Explain your science and evidence to the right audience

Campaign

Connect your message across audiences and channels

Campaign

Connect your message across audiences and channels

Branding

Create a recognizable, consistent identity

Branding

Create a recognizable, consistent identity

Digital

Build websites and tools people can use

Digital

Build websites and tools people can use

Production

Produce, adapt, and update your materials

Production

Produce, adapt, and update your materials

Client

EyePoint

Goal

Destination in sight

Year

2024

Services

Brand identity illustration, gift set and packaging

About

For most programs, trial identities are generic, indistinct marks that carry little meaning of their own. When EyePoint launched two global Phase 3 trials for EYP-1901, they asked Steadfast to go further.

See more complex science, made clear.

CASE STUDY

Where standard of care meets standard of comfort

See the Work

Read case

CASE STUDY

Calling B.S. on dry eye's status quo

See the Work

Read case

Let’s craft your story.

A challenge to wrangle, a brand to build, a launch to get right. Tell us what’s on deck, and let’s get to work.

Get in touch